These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Arahata K, Engel AG. Ann Neurol; 1984 Aug; 16(2):193-208. PubMed ID: 6383191 [Abstract] [Full Text] [Related]
3. Idiopathic inflammatory myopathies. Immunohistochemical analysis of the major histocompatibility complex antigen expression, inflammatory infiltrate phenotype and activation cell markers. Pedrol E, Grau JM, Casademont J, Cid MC, Masanés F, Fernandez-Sola J, Urbano-Márquez A. Clin Neuropathol; 1995 Aug; 14(3):179-84. PubMed ID: 7671462 [Abstract] [Full Text] [Related]
4. Evidence for MHC I-restricted CD8+ T-cell-mediated immunopathology in canine masticatory muscle myositis and polymyositis. Neumann J, Bilzer T. Muscle Nerve; 2006 Feb; 33(2):215-24. PubMed ID: 16270307 [Abstract] [Full Text] [Related]
5. T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells. Fasth AE, Dastmalchi M, Rahbar A, Salomonsson S, Pandya JM, Lindroos E, Nennesmo I, Malmberg KJ, Söderberg-Nauclér C, Trollmo C, Lundberg IE, Malmström V. J Immunol; 2009 Oct 01; 183(7):4792-9. PubMed ID: 19752224 [Abstract] [Full Text] [Related]
6. Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells. Nagaraju K, Raben N, Villalba ML, Danning C, Loeffler LA, Lee E, Tresser N, Abati A, Fetsch P, Plotz PH. Clin Immunol; 1999 Aug 01; 92(2):161-9. PubMed ID: 10444360 [Abstract] [Full Text] [Related]
7. Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies: CD4+ T cells cause muscle cell injury directly in polymyositis. Sugiura T, Murakawa Y, Nagai A, Kondo M, Kobayashi S. Arthritis Rheum; 1999 Feb 01; 42(2):291-8. PubMed ID: 10025923 [Abstract] [Full Text] [Related]
8. Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis. Dorph C, Englund P, Nennesmo I, Lundberg IE. Ann Rheum Dis; 2006 Dec 01; 65(12):1565-71. PubMed ID: 16831829 [Abstract] [Full Text] [Related]
9. The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy. Haslbeck KM, Friess U, Schleicher ED, Bierhaus A, Nawroth PP, Kirchner A, Pauli E, Neundörfer B, Heuss D. Acta Neuropathol; 2005 Sep 01; 110(3):247-54. PubMed ID: 15986224 [Abstract] [Full Text] [Related]
11. [Clinical characteristics and muscle histopathology in polymyositis positive anti-hepatitis with C virus antibody]. Ayabe M, Kawamoto M, Ijima H, Hino H, Shoji H. Rinsho Shinkeigaku; 1997 Mar 01; 37(3):208-11. PubMed ID: 9217418 [Abstract] [Full Text] [Related]
12. Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cells. Page G, Chevrel G, Miossec P. Arthritis Rheum; 2004 Jan 01; 50(1):199-208. PubMed ID: 14730617 [Abstract] [Full Text] [Related]
13. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis. Dimitri D, Benveniste O, Dubourg O, Maisonobe T, Eymard B, Amoura Z, Jean L, Tiev K, Piette JC, Klatzmann D, Herson S, Boyer O. Brain; 2006 Apr 01; 129(Pt 4):986-95. PubMed ID: 16455793 [Abstract] [Full Text] [Related]
14. Cellular distribution of proteolytic enzymes in the skeletal muscle of sarcoid myopathy. Kumamoto T, Yukishige K, Ito T, Nagao S, Mori T, Ueyama H, Tsumura H, Tsuda T. Acta Neuropathol; 2002 Jul 01; 104(1):38-44. PubMed ID: 12070662 [Abstract] [Full Text] [Related]
15. Expression of CCR7 and its ligands CCL19/CCL21 in muscles of polymyositis. Tateyama M, Fujihara K, Misu T, Feng J, Onodera Y, Itoyama Y. J Neurol Sci; 2006 Nov 15; 249(2):158-65. PubMed ID: 16887149 [Abstract] [Full Text] [Related]
16. Eosinophilia myalgia syndrome: I. Immunocytochemical evidence for a T-cell-mediated immune effector response. Emslie-Smith AM, Engel AG, Duffy J, Bowles CA. Ann Neurol; 1991 May 15; 29(5):524-8. PubMed ID: 1859182 [Abstract] [Full Text] [Related]
17. [MHC class I antigens, CD4 and CD8 expressions in polymyositis and dermatomyositis]. Graça CR, Kouyoumdjian JA. Rev Bras Reumatol; 2015 May 15; 55(3):203-8. PubMed ID: 25600456 [Abstract] [Full Text] [Related]
18. Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. Goebels N, Michaelis D, Engelhardt M, Huber S, Bender A, Pongratz D, Johnson MA, Wekerle H, Tschopp J, Jenne D, Hohlfeld R. J Clin Invest; 1996 Jun 15; 97(12):2905-10. PubMed ID: 8675705 [Abstract] [Full Text] [Related]
19. CCR7+ myeloid dendritic cells together with CCR7+ T cells and CCR7+ macrophages invade CCL19+ nonnecrotic muscle fibers in inclusion body myositis. Tateyama M, Fujihara K, Misu T, Itoyama Y. J Neurol Sci; 2009 Apr 15; 279(1-2):47-52. PubMed ID: 19171354 [Abstract] [Full Text] [Related]
20. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity. Schmidt J, Rakocevic G, Raju R, Dalakas MC. Brain; 2004 May 15; 127(Pt 5):1182-90. PubMed ID: 15047591 [Abstract] [Full Text] [Related] Page: [Next] [New Search]